The Scleroderma Diagnostics and Therapeutics Market in the US is expanding as healthcare providers increasingly emphasize early diagnosis, disease monitoring, and comprehensive management of scleroderma and its associated complications. The condition can affect the skin and internal organs, creating demand for diagnostic approaches and therapies that help assess disease progression...